Kristina Lybecker

@DrLybecker

Professor of Economics fields of expertise: IP, innovation, global health, pharmaceutical policy, neglected diseases

Joined March 2013
1 Photo or video Photos and videos

Tweets

You blocked @DrLybecker

Are you sure you want to view these Tweets? Viewing Tweets won't unblock @DrLybecker

  1. 11 May 2017

    Don’t overlook stronger IP as a tool to improve access to innovative treatments.

    1 retweet 1 like
    Undo
  2. 9 May 2017

    . Fair Pricing Forum too narrowly focused on price setting to improve access.

    1 retweet
    Undo
  3. 16 May 2016

    The UN High Level Panel on Innovation and Access. Are they ignoring the real barriers to access to medicines?

    2 likes
    Undo
  4. 19 Sep 2015

    My post in IP Watchdog:

    Undo
  5. Retweeted
    14 Sep 2015

    For public health, Australia should protect biologics with both robust patents and RDP - by

    3 retweets
    Undo
  6. Retweeted
    15 Sep 2015

    Why is important to the pharmaceutical industry?

    9 retweets 3 likes
    Undo
  7. 14 Sep 2015

    Nat'l governments determine pricing and reimbursement of medicines. This won't change under the TTIP

    Undo
  8. 11 Sep 2015

    Increased efficiency can generate cost savings and translate into greater investment in the search for cures

    1 like
    Undo
  9. 11 Sep 2015

    TTIP will harmonize of regulatory systems enabling quicker patient access to new treatments and cures

    1 reply 1 like
    Undo
  10. 11 Sep 2015

    TTIP will generate research cooperation, foster sharing of knowledge, and speed the launch of new treatments

    2 retweets
    Undo
  11. Retweeted
    3 Sep 2015

    .: IP-intensive industries have double the sales & capital spending than non-IP-intensive industries

    1 retweet
    Undo
  12. 8 Sep 2015

    Looking forward to discussing this Friday how the EU-US trade agreement impacts patients and industry

    3 retweets 3 likes
    Undo
  13. 24 Mar 2015

    IP Protection is Key to U.S. Job Creation via

    Undo
  14. 8 Mar 2015

    can eliminate protectionist tariffs that raise the prices of medicines for the poorest and weakest.

    2 replies 3 retweets
    Undo
  15. Retweeted
    5 Mar 2015

    . explains how undermining the data exclusivity provisions in threatens the future of .

    2 retweets 1 like
    Undo
  16. Retweeted
    6 Mar 2015

    Is the future of the most promising medical frontier under attack? weighs in:

    1 retweet
    Undo
  17. 8 Mar 2015

    Nothing in stops medicines that have exhausted their patent lives from becoming available as generics

    1 reply 1 retweet
    Undo
  18. 3 Mar 2015

    My guest blog "Protect the Incentives for Hope, Treatment & Cures"

    2 retweets 1 like
    Undo
  19. 26 Feb 2015

    Better awareness, screening, medicines can all reduce the global burden of familial hypercholesterolemia (FH)

    Undo
  20. 22 Feb 2015

    The therapeutic and economic value of incremental pharmaceutical innovation.

    2 retweets 2 likes
    Undo

@DrLybecker hasn't Tweeted yet.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.

    You may also like

    ·